Literature DB >> 18430532

Gene expression analysis of human otosclerotic stapedial footplates.

Megan Ealy1, Wenjie Chen, Gi-Yung Ryu, Jae-Geun Yoon, D Bradley Welling, Marlan Hansen, Anup Madan, Richard J H Smith.   

Abstract

Otosclerosis is a complex disease that results in a common form of conductive hearing loss due to impaired mobility of the stapes. Stapedial motion becomes compromised secondary to invasion of otosclerotic foci into the stapedio-vestibular joint. Although environmental factors and genetic causes have been implicated in this process, the pathogenesis of otosclerosis remains poorly understood. To identify molecular contributors to otosclerosis we completed a microarray study of otosclerotic stapedial footplates. Stapes footplate samples from otosclerosis and control patients were used in the analysis. One-hundred-and-ten genes were found to be differentially expressed in otosclerosis samples. Ontological analysis of differentially expressed genes in otosclerosis provides evidence for the involvement of a number of pathways in the disease process that include interleukin signaling, inflammation and signal transduction, suggesting that aberrant regulation of these pathways leads to abnormal bone remodeling. Functional analyses of genes from this study will enhance our understanding of the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18430532      PMCID: PMC2442649          DOI: 10.1016/j.heares.2008.03.001

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  33 in total

Review 1.  The aetiology of otosclerosis: a review of the literature.

Authors:  D J Menger; R A Tange
Journal:  Clin Otolaryngol Allied Sci       Date:  2003-04

2.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  PANTHER: a library of protein families and subfamilies indexed by function.

Authors:  Paul D Thomas; Michael J Campbell; Anish Kejariwal; Huaiyu Mi; Brian Karlak; Robin Daverman; Karen Diemer; Anushya Muruganujan; Apurva Narechania
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

4.  Prevalence of histologic otosclerosis: an unbiased temporal bone study in Caucasians.

Authors:  F Declau; M van Spaendonck; J P Timmermans; L Michaels; J Liang; J P Qiu; P Van de Heyning
Journal:  Adv Otorhinolaryngol       Date:  2007

5.  A seventh locus for otosclerosis, OTSC7, maps to chromosome 6q13-16.1.

Authors:  Melissa Thys; Kris Van Den Bogaert; Vassiliki Iliadou; Kathleen Vanderstraeten; Nele Dieltjens; Isabelle Schrauwen; Wenjie Chen; Nikolaos Eleftheriades; Maria Grigoriadou; Robert Jan Pauw; Cor R W J Cremers; Richard J H Smith; Michael B Petersen; Guy Van Camp
Journal:  Eur J Hum Genet       Date:  2007-01-10       Impact factor: 4.246

6.  Association of bone morphogenetic proteins with otosclerosis.

Authors:  Isabelle Schrauwen; Melissa Thys; Kathleen Vanderstraeten; Erik Fransen; Nele Dieltjens; Jeroen R Huyghe; Megan Ealy; Mireille Claustres; Cor R W J Cremers; Ingeborg Dhooge; Frank Declau; Paul Van de Heyning; Robert Vincent; Thomas Somers; Erwin Offeciers; Richard J H Smith; Guy Van Camp
Journal:  J Bone Miner Res       Date:  2008-04       Impact factor: 6.741

7.  Immunohistochemical evidence of BMP-2, -4 and -7 activity in otospongiosis.

Authors:  Goetz Lehnerdt; Claus Unkel; Klaus Alfred Metz; Klaus Jahnke; Andreas Neumann
Journal:  Acta Otolaryngol       Date:  2008-01       Impact factor: 1.494

8.  Linkage of otosclerosis to a third locus (OTSC3) on human chromosome 6p21.3-22.3.

Authors:  W Chen; C A Campbell; G E Green; K Van Den Bogaert; C Komodikis; L S Manolidis; E Aconomou; Y Kyamides; K Christodoulou; C Faghel; C M Giguére; R L Alford; S Manolidis; G Van Camp; R J H Smith
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

9.  A new locus for otosclerosis, OTSC8, maps to the pericentromeric region of chromosome 9.

Authors:  Insaf Bel Hadj Ali; Melissa Thys; Najeh Beltaief; Isabelle Schrauwen; Nele Hilgert; Kathleen Vanderstraeten; Nele Dieltjens; Emna Mnif; Slah Hachicha; Ghazi Besbes; Saïda Ben Arab; Guy Van Camp
Journal:  Hum Genet       Date:  2008-01-26       Impact factor: 4.132

10.  The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations.

Authors:  Melissa Thys; Isabelle Schrauwen; Kathleen Vanderstraeten; Katrien Janssens; Nele Dieltjens; Kris Van Den Bogaert; Erik Fransen; Wenjie Chen; Megan Ealy; Mireille Claustres; Cor R W J Cremers; Ingeborg Dhooge; Frank Declau; Jos Claes; Paul Van de Heyning; Robert Vincent; Thomas Somers; Erwin Offeciers; Richard J H Smith; Guy Van Camp
Journal:  Hum Mol Genet       Date:  2007-06-22       Impact factor: 6.150

View more
  4 in total

Review 1.  Etiopathogenesis of otosclerosis.

Authors:  Tamás Karosi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

2.  The risks of RELN polymorphisms and its expression in the development of otosclerosis.

Authors:  Saurabh Priyadarshi; Kirtal Hansdah; Neha Singh; Amal Bouzid; Chinmay Sundar Ray; Khirod Chandra Panda; Narayan Chandra Biswal; Ashim Desai; Jyotish Chandra Choudhury; Adel Tekari; Saber Masmoudi; Puppala Venkat Ramchander
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

3.  Mutations and altered expression of SERPINF1 in patients with familial otosclerosis.

Authors:  Joanna L Ziff; Michael Crompton; Harry R F Powell; Jeremy A Lavy; Christopher P Aldren; Karen P Steel; Shakeel R Saeed; Sally J Dawson
Journal:  Hum Mol Genet       Date:  2016-04-07       Impact factor: 6.150

4.  Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.

Authors:  Kathleen Cheung; Matthew J Barter; Julia Falk; Carole J Proctor; Louise N Reynard; David A Young
Journal:  FASEB J       Date:  2020-02-14       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.